The social stigma surrounding an anal cancer diagnosis has traditionally prevented open
discussions about this disease. However, as recent treatment options and an increasing rate …

Answer questions and earn CME/CNE The management of squamous cell carcinomas of
the anal canal has evolved from surgery as first‐line treatment to curative chemoradiation …

Anal cancer is a rare cancer that accounts for about 2% of all gastrointestinal tract
malignancies. Among anal cancer, squamous cell cancer is the most common malignancy …

Despite the small number of patients affected by carcinoma of the anal canal it remains one
of the most challenging cancers to treat. For although it is one of the few malignancies that …

Although anal cancer is a rare disease, its incidence is increasing in men and women
worldwide. The most important risk factors are behaviors that predispose individuals to …

Anal cancer represents less than 1% of all new cancers diagnosed annually in the United
States. Yet, despite the relative paucity of cases, the incidence of anal cancer has seen a …

Anal cancer accounts for only 1.5% of gastrointestinal malignancies but this disease has
shown a steady increase in incidence particularly in HIV positive males. The understanding …

Anal cancers (AC) are relatively rare tumors. Their incidence is increasing, particularly
among men who have sex with other men due to widespread infection by human papilloma …

Radiotherapy with concurrent chemotherapy is the standard of care for patients with
nonmetastatic squamous cell anal cancer. Most patients treated with chemoradiotherapy …

The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of
patients with squamous cell carcinoma of the anal canal or perianal region. Primary …